Cited by 22Fungal Infections and StudiesAntifungal resistance and susceptibilityFungal Plant Pathogen Control

Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil

Moreira, Izabela de Mesquita Bárcia, Cortez, Ana Cláudia Alves, de Souza, Érica Simplício, Pinheiro, Silviane Bezerra, de Souza Oliveira, Juliana Gomes, Sadahiro, Aya, Cruz, Katia Santana, Matsuura, Ani Beatriz Jackisch +3 more·2022·Medical Mycology

Abstract

Heteroresistance, defined as the occurrence of apparently homogeneous subpopulations of microbial cells showing different levels of antimicrobial susceptibility is a problem that has been associated with therapeutical failure in cryptococcosis. The purpose of the study was an investigation on the level of heteroresistance to fluconazole (LHF) as observed in clinical and environmental C. neoformans/C. gattii complex species isolates from Amazonas State (AM), Brazil. A total of 45 isolates and 9 type strains were analyzed. The assessments comprised testing for minimal inhibitory concentrations (MICs), for LHFs, for the strains’ capacity of adaptation to high fluconazole (FLC) concentrations above the LHF, and for the stability of the heteroresistance phenomenon. The mean MICs for clinical isolates of C. gattii (6.4 µg/ml) were higher than those observed for environmental C. gattii strains (1.7 µg/ml) and clinical (3.7 µg/ml) as well as environmental (1.5 µg/ml) C. neoformans isolates. The phenomenon of heteroresistance to FLC was recorded for all isolates. On average, the LHF (8–256 µg/ml) of the isolates was 16 times higher than the FLC MICs (0.5–16 µg/ml) and a proportion of 85% isolates showed LHFs ≥ 16 µg/ml, 40% even ≥ 32 µg/ml. According to the adaptation assay, a considerable number of isolates (58%) showed the capacity of adaptation to MICs even higher than the initially recorded LHF. After the adaptation experiment, the adaptative-LHF values (8–512 µg/ml) were about 60 times higher than the original MIC values. After nine subsequent passages in drug-free broth, the isolates had their adaptative-LHF reduced. However, the LHF did not revert to the initially measured level. Our findings challenge the clinical interpretation of the antifungal MIC testing and motivate future studies correlating the levels of heteroresistance and parameters like LHF and adaptative-LHF with cryptococcosis-associated morbidity and mortality. Lay summary: Cryptococcosis affects many people and is caused by fungi of the Cryptococcus neoformans/Cryptococcus gattii complexes. These agents appear to become more resistant to antifungals when exposed to increasing concentrations of antifungals due to a phenomenon called heteroresistance.

Integrity signals

Registry

Crossref · 10.1093/mmy/myac005

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased emergence of heteroresistance in clinical versus environmental isolates supports the induction effect of antifungal exposure.

    “Several studies have confirmed the increased emergence of heteroresistance in clinical, compared with environmental, isolates, supporting the induction effect of antifungal exposure [101,158].”
  • Several studies have confirmed increased emergence of heteroresistance in clinical compared with environmental isolates.

    “Several studies have confirmed the increased emergence of heteroresistance in clinical, compared with environmental, isolates, supporting the induction effect of antifungal exposure [101,158].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Moreira, I. D. M. B., Cortez, A. C. A., de Souza, É. S., Pinheiro, S. B., de Souza Oliveira, J. G., Sadahiro, A., Cruz, K. S., Matsuura, A. B. J., Melhem, M. D. S. C., Frickmann, H., & de Souza, J. V. B.
Affiliations
  • Universidade Federal do Amazonas (BR)
  • Instituto Nacional de Pesquisas da Amazônia (BR)
  • Superior School of Technology, Amazon State University- UEA, 69050-020, Manaus, Brazil
  • Collection of Microorganisms of Medical Interest, Coordination of Society, Environment and Health, National Institute for Amazonian Research- INPA, 69060-001, Manaus, Brazil
  • Laboratory of Mycology, Tropical Medicine Foundation Dr. Heitor Vieira Dourado- FMT- HVD, 69040-000, Manaus, Brazil
  • Fiocruz Amazônia (BR)
  • Universidade Federal de Mato Grosso do Sul (BR)
  • Bundeswehrkrankenhaus (DE)
  • Laboratory of Mycology, Coordination of Society, Environment and Health, National Institute for Amazonian Research-INPA, 69060-001, Manaus, Brazil
Venue
Medical Mycology
Published
2022-01-27
Volume
60
Issue
3
ISSN
  • 0268-1218 (ISSN-L)
  • 1369-3786
  • 1460-2709
OpenAlex
W4206998595
Cited by
22
References
29
Citations by year
2026: 2 · 2025: 8 · 2024: 6 · 2023: 4 · 2022: 2
FWCI
3.61
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Mycology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Fundação de Amparo à Pesquisa do Estado do Amazonas (001/2017)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
Topics
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
Keywords
cryptococcosis, antifungal susceptibility, minimum inhibitory concentration, clinical isolates, environmental isolates, Amazonas, type strain
MeSH terms
Animals, Antifungal Agents, Brazil, Cryptococcosis, Cryptococcus neoformans, Microbial Sensitivity Tests, Fluconazole, Drug Resistance, Fungal, Cryptococcus gattii

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review